Source: Arthritis Care & Research. Unidade: FM
Subjects: INFLUENZA (IMUNOLOGIA), VACINAS VIRAIS (EFEITOS ADVERSOS), REGRESSÃO LOGÍSTICA, IMUNOLOGIA CELULAR, ANTICORPOS (PRODUÇÃO), LÚPUS ERITEMATOSO SISTÊMICO, FEBRE REUMÁTICA (IMUNOLOGIA)
ABNT
CAMPOS, Lucia M. A. et al. High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. Arthritis Care & Research, v. 65, n. 7, p. 1121-1127, 2013Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/acr.21948/pdf. Acesso em: 02 nov. 2024.APA
Campos, L. M. A., Silva, C. A., Aikawwa, N. E., Jesus, A. A., Moraes, J. C. B., Miraglia, J., et al. (2013). High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. Arthritis Care & Research, 65( 7), 1121-1127. doi:10.1002/acr.21948NLM
Campos LMA, Silva CA, Aikawwa NE, Jesus AA, Moraes JCB, Miraglia J, Ishida MA, Bueno C, Pereira RMR, Bonfa E. High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus [Internet]. Arthritis Care & Research. 2013 ; 65( 7): 1121-1127.[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/acr.21948/pdfVancouver
Campos LMA, Silva CA, Aikawwa NE, Jesus AA, Moraes JCB, Miraglia J, Ishida MA, Bueno C, Pereira RMR, Bonfa E. High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus [Internet]. Arthritis Care & Research. 2013 ; 65( 7): 1121-1127.[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/acr.21948/pdf